NIH Research Matters
October 2011 Archive
October 31, 2011
Variants in the APOL1 gene account for the increased risk of kidney disease among African Americans, according to a new report. The finding may lead to screening tests and earlier treatment, although further research is required.
Weekly classes of yoga or intensive stretching are equally effective at reducing low back pain and improving back movement, a new study reports.
Rats exposed to an antidepressant just before and after birth had altered behaviors and substantial brain abnormalities. The findings raise questions about the use of antidepressants during pregnancy.
October 24, 2011
A massive effort to sequence and compare 29 mammalian genomes has shed new light on the “dark matter” of the genome, the over 98% of DNA that doesn’t code for proteins.
Scientists corrected sickle cell disease in adult laboratory mice by activating production of a special blood protein normally produced only before birth. The approach may lead to new treatments for the disorder.
Scientists found a protein that helps create a buffer zone between intestinal walls and the bacteria within. The finding might improve understanding of inflammatory bowel disease and other digestive disorders.
OCTOBER 17, 2011
Avian flu-fighting antibodies rose significantly in adults who received a DNA “primer” vaccine followed by an avian flu shot. The technique holds promise for blocking several strains of influenza.
Physicians often fail to counsel their young adult patients about excessive alcohol use, a new study found.
A new study found that vitamin E, once thought to reduce the risk of prostate cancer, may actually increase the risk.
OCTOBER 3, 2011
A genetic variant may explain why some people with asthma don’t respond well to inhaled corticosteroids, the most widely prescribed medicine for long-term asthma control. The finding might eventually lead to more effective, personalized asthma treatments.
A small clinical trial has found that daily doses of an insulin nasal spray can slow memory loss and preserve thinking skills in people with mild to moderate Alzheimer’s disease.
Saw palmetto, a widely used herbal dietary supplement, was no better than placebo in reducing urinary problems caused by prostate enlargement, according to a new study.
NIH Research Matters
Bldg. 31, Rm. 5B64A, MSC 2094
Bethesda, MD 20892-2094
About NIH Research Matters
Editor: Harrison Wein, Ph.D.
Assistant Editors: Vicki Contie, Carol Torgan, Ph.D.
NIH Research Matters is a weekly update of NIH research highlights from the Office of Communications and Public Liaison, Office of the Director, National Institutes of Health.